Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29618597)

  • 1. Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and Its Agonists.
    Shen J; Zhang N; Lin YN; Xiang P; Liu XB; Shan PF; Hu XY; Zhu W; Tang YL; Webster KA; Cai R; Schally AV; Wang J; Yu H
    Circ Res; 2018 May; 122(10):1395-1408. PubMed ID: 29618597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone.
    Xiang P; Jing W; Lin Y; Liu Q; Shen J; Hu X; Chen J; Cai R; Hare JM; Zhu W; Schally AV; Yu H
    J Cell Physiol; 2021 Dec; 236(12):8197-8207. PubMed ID: 34224586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice.
    Ren HL; Cai R; Xue R; Zhang Y; Xu Q; Zhang X; Cai R; Sha W; Schally AV; Zhou MS
    Front Cardiovasc Med; 2023; 10():1102525. PubMed ID: 36742073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
    Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
    Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
    Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 Enhances Vascular Calcification and Osteogenic Differentiation of Vascular Smooth Muscle Cells Through TRPM7 Activation.
    Zhang K; Zhang Y; Feng W; Chen R; Chen J; Touyz RM; Wang J; Huang H
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1933-1943. PubMed ID: 28860220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia Triggers Osteochondrogenic Differentiation of Vascular Smooth Muscle Cells in an HIF-1 (Hypoxia-Inducible Factor 1)-Dependent and Reactive Oxygen Species-Dependent Manner.
    Balogh E; Tóth A; Méhes G; Trencsényi G; Paragh G; Jeney V
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1088-1099. PubMed ID: 31070451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vascular peroxidase 1 in ox-LDL-induced vascular smooth muscle cell calcification.
    Tang Y; Xu Q; Peng H; Liu Z; Yang T; Yu Z; Cheng G; Li X; Zhang G; Shi R
    Atherosclerosis; 2015 Dec; 243(2):357-63. PubMed ID: 26520887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells.
    Liao XB; Zhang ZY; Yuan K; Liu Y; Feng X; Cui RR; Hu YR; Yuan ZS; Gu L; Li SJ; Mao DA; Lu Q; Zhou XM; de Jesus Perez VA; Yuan LQ
    Endocrinology; 2013 Sep; 154(9):3344-52. PubMed ID: 23798596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
    Cunha SR; Mayo KE
    Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
    Schally AV; Varga JL; Engel JB
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the pituitary somatotroph cell by GHRH and its receptor.
    Mayo KE; Miller T; DeAlmeida V; Godfrey P; Zheng J; Cunha SR
    Recent Prog Horm Res; 2000; 55():237-66; discussion 266-7. PubMed ID: 11036940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression.
    Kim JH; Choi YK; Do JY; Choi YK; Ha CM; Lee SJ; Jeon JH; Lee WK; Choi HS; Park KG; Lee IK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2384-90. PubMed ID: 26404484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling.
    Gan J; Ke X; Jiang J; Dong H; Yao Z; Lin Y; Lin W; Wu X; Yan S; Zhuang Y; Chu WK; Cai R; Zhang X; Cheung HS; Block NL; Pang CP; Schally AV; Zhang H
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14745-14750. PubMed ID: 27930339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.
    Aleppo G; Moskal SF; De Grandis PA; Kineman RD; Frohman LA
    Endocrinology; 1997 Mar; 138(3):1058-65. PubMed ID: 9048609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.